Carilion Clinic

Insider

First SEC filing: April 21, 2017 · Latest: April 21, 2017

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 10, 2019	RWAYL	P	293,572	$15.16	$4,450,552	1,739,837 Direct	+20.30%	Acquired	65.8% (price as of 2026-08-21)
Jan. 2, 2019	RWAYL	P	395,306	$15.19	$6,004,698	1,409,038 Direct	+39.00%	Acquired	65.5% (price as of 2026-08-21)
Sept. 14, 2018	RWAYL	P	181,530	$15.02	$2,726,581	990,720 Direct	+22.43%	Acquired	67.4% (price as of 2026-08-21)
Dec. 8, 2017	RWAYL	P	196,632	$15.00	$2,949,480	787,879 Direct	+33.26%	Acquired	67.6% (price as of 2026-08-21)
Aug. 28, 2017	RWAYL	P	258,803	$15.00	$3,882,045	591,247 Direct	+77.85%	Acquired	67.6% (price as of 2026-08-21)
June 12, 2017	RWAYL	P	181,889	$15.00	$2,728,335	332,445 Direct	+120.81%	Acquired	67.6% (price as of 2026-08-21)
April 19, 2017	RWAYL	P	110,855	$15.00	$1,662,825	150,556 Direct	+279.22%	Acquired	67.6% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
April 21, 2017	RWAYL	Common Stock, par value $0.01 per share	39,701	Direct